Dr. Michael Shane Hamman, MD

Dr. Hamman practices at Cosmetic Laser Dermatology in San Diego, California.

Dr. Hamman's NPI, 1538346911, was assigned on January 28, 2008. Dr. Hamman graduated from University Of Washington School Of Medicine in 2005. Dr. Hamman holds California license A97551.

Dr. Hamman's primary practice is Cosmetic Laser Dermatology, at 9339 Genesee Avenue, Suite 300, San Diego, CA 92121. The practice phone is (858) 657-1002.

Dr. Hamman's primary practice is Cosmetic Laser Dermatology in San Diego, California. The medical group on file is West Dermatology. Dmand AI also links Dr. Hamman to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Hamman's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamman practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Hamman's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Hamman is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Hamman's licenses on file in 2 states: California and Arizona.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis and skin cyst among the conditions Dr. Hamman treats.

CMS data shows 1,098 Medicare services from Dr. Hamman across 21 procedure codes in 2024, for 374 Medicare patients. Medicare paid $362,004 for them. Every service was in an office.

CMS counts 374 Medicare patients who saw Dr. Hamman in 2024. The largest group is 65 to 74, with 164 patients. 72% of them have high cholesterol, and 63% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hamman's median patient age at 70, with 47% women.

In 2024, Dr. Hamman wrote 365 Medicare Part D claims for 260 patients. 99% of them were for generic drugs. CMS names the drug for 325 of them, across 6 drugs with 11 or more claims each, at $3,832 in total drug cost. In 2023, CMS named 271 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Hamman for performance year 2024, reported as part of a group. Dr. Hamman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 189 procedures of melanoma (skin cancer) excision by Dr. Hamman, more than 97% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Hamman. Dr. Hamman's most frequent co-authors are Mitchel Paul Goldman, MD, Sabrina Guillen Fabi, MD and Shang I B. Jiang, MD.

CMS Open Payments shows 227 general payments to Dr. Hamman from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $716.

Dr. Hamman graduated from University Of Washington School Of Medicine in 2005.

Dr. Hamman is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.